Gastrointestinal mucosal toxicities from immune checkpoint inhibitors: Current understanding and future directions.

Dougan, Michael

Dougan, Michael.

Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Immunol Rev ; 318(1): 11-21, 2023 09.

Article en En | MEDLINE | ID: mdl-37455375

Asunto(s)

Colitis; Neoplasias; Humanos; Inhibidores de Puntos de Control Inmunológico/efectos adversos; Estudios Retrospectivos; Colitis/inducido químicamente; Colitis/tratamiento farmacológico

Palabras clave

immunotherapies; inflammation; inflammatory bowel disease; mucosa; tolerance/suppression/anergy; tumor immunity

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Colitis / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google